Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 360.55 Billion JPY | -24.57% |
| 2023 | 397.21 Billion JPY | -11.95% |
| 2022 | 451.14 Billion JPY | 6.99% |
| 2021 | 421.67 Billion JPY | 30.69% |
| 2020 | 322.65 Billion JPY | 69.49% |
| 2019 | 190.37 Billion JPY | -25.78% |
| 2018 | 256.48 Billion JPY | -13.18% |
| 2017 | 295.4 Billion JPY | -10.92% |
| 2016 | 331.61 Billion JPY | -6.44% |
| 2015 | 354.42 Billion JPY | -14.77% |
| 2014 | 415.83 Billion JPY | -25.8% |
| 2013 | 560.39 Billion JPY | -12.77% |
| 2012 | 642.42 Billion JPY | -0.98% |
| 2011 | 648.78 Billion JPY | -1.92% |
| 2010 | 661.48 Billion JPY | 0.19% |
| 2009 | 660.22 Billion JPY | 0.53% |
| 2008 | 656.75 Billion JPY | 38.03% |
| 2007 | 475.81 Billion JPY | 3.89% |
| 2006 | 458.01 Billion JPY | 19.89% |
| 2005 | 382.04 Billion JPY | 58.29% |
| 2004 | 241.36 Billion JPY | 19.58% |
| 2003 | 201.84 Billion JPY | -5.59% |
| 2002 | 213.79 Billion JPY | -7.26% |
| 2001 | 230.51 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 348.41 Billion JPY | 0.71% |
| 2024 Q1 | 345.96 Billion JPY | -12.9% |
| 2024 FY | 360.55 Billion JPY | -9.23% |
| 2024 Q4 | 360.55 Billion JPY | 18.34% |
| 2024 Q3 | 304.67 Billion JPY | -12.55% |
| 2023 Q2 | 389.79 Billion JPY | -1.27% |
| 2023 FY | 397.21 Billion JPY | -11.95% |
| 2023 Q4 | 397.21 Billion JPY | 12.61% |
| 2023 Q1 | 394.79 Billion JPY | -12.49% |
| 2023 Q3 | 352.73 Billion JPY | -9.51% |
| 2022 FY | 451.14 Billion JPY | 6.99% |
| 2022 Q1 | 335.07 Billion JPY | -22.53% |
| 2022 Q3 | 393.1 Billion JPY | 17.21% |
| 2022 Q2 | 335.37 Billion JPY | 0.09% |
| 2022 Q4 | 451.14 Billion JPY | 14.77% |
| 2021 Q2 | 382.73 Billion JPY | -3.33% |
| 2021 Q1 | 395.92 Billion JPY | 40.94% |
| 2021 FY | 421.67 Billion JPY | 30.69% |
| 2021 Q4 | 432.52 Billion JPY | 20.31% |
| 2021 Q3 | 359.49 Billion JPY | -6.07% |
| 2020 Q3 | 267.12 Billion JPY | -5.14% |
| 2020 Q1 | 181.54 Billion JPY | 0.12% |
| 2020 Q4 | 280.91 Billion JPY | 5.16% |
| 2020 Q2 | 281.58 Billion JPY | 55.11% |
| 2020 FY | 322.65 Billion JPY | 69.49% |
| 2019 Q4 | 181.33 Billion JPY | -14.25% |
| 2019 FY | 190.37 Billion JPY | -25.78% |
| 2019 Q2 | 205.42 Billion JPY | -17.9% |
| 2019 Q1 | 250.2 Billion JPY | 0.9% |
| 2019 Q3 | 211.47 Billion JPY | 2.95% |
| 2018 Q2 | 262.56 Billion JPY | -7.53% |
| 2018 Q1 | 283.95 Billion JPY | -0.7% |
| 2018 FY | 256.48 Billion JPY | -13.18% |
| 2018 Q4 | 247.97 Billion JPY | -5.65% |
| 2018 Q3 | 262.81 Billion JPY | 0.09% |
| 2017 Q3 | 306.96 Billion JPY | 3.1% |
| 2017 Q2 | 297.73 Billion JPY | -7.34% |
| 2017 Q1 | 321.3 Billion JPY | 0.31% |
| 2017 FY | 295.4 Billion JPY | -10.92% |
| 2017 Q4 | 285.97 Billion JPY | -6.84% |
| 2016 Q1 | 350.27 Billion JPY | -1.17% |
| 2016 Q4 | 320.3 Billion JPY | 1.94% |
| 2016 Q2 | 316.13 Billion JPY | -9.75% |
| 2016 FY | 331.61 Billion JPY | -6.44% |
| 2016 Q3 | 314.2 Billion JPY | -0.61% |
| 2015 Q1 | 398.95 Billion JPY | -4.06% |
| 2015 FY | 354.42 Billion JPY | -14.77% |
| 2015 Q2 | 359.94 Billion JPY | -9.78% |
| 2015 Q3 | 367.08 Billion JPY | 1.98% |
| 2015 Q4 | 354.42 Billion JPY | -3.45% |
| 2014 Q4 | 415.83 Billion JPY | -4.09% |
| 2014 FY | 415.83 Billion JPY | -25.8% |
| 2014 Q3 | 433.55 Billion JPY | 0.82% |
| 2014 Q2 | 430.02 Billion JPY | -8.85% |
| 2014 Q1 | 471.77 Billion JPY | -15.81% |
| 2013 Q2 | 586.23 Billion JPY | -8.17% |
| 2013 Q1 | 638.37 Billion JPY | -0.63% |
| 2013 FY | 560.39 Billion JPY | -12.77% |
| 2013 Q4 | 560.39 Billion JPY | -6.01% |
| 2013 Q3 | 596.22 Billion JPY | 1.7% |
| 2012 Q2 | 665.28 Billion JPY | -5.45% |
| 2012 Q3 | 636.83 Billion JPY | -4.28% |
| 2012 Q4 | 642.42 Billion JPY | 0.88% |
| 2012 FY | 642.42 Billion JPY | -0.98% |
| 2012 Q1 | 703.62 Billion JPY | 8.45% |
| 2011 FY | 648.78 Billion JPY | -1.92% |
| 2011 Q2 | 647.94 Billion JPY | -0.89% |
| 2011 Q3 | 651.83 Billion JPY | 0.6% |
| 2011 Q4 | 648.78 Billion JPY | -0.47% |
| 2011 Q1 | 653.73 Billion JPY | -1.17% |
| 2010 Q1 | 660.35 Billion JPY | 0.02% |
| 2010 FY | 661.48 Billion JPY | 0.19% |
| 2010 Q3 | 655.95 Billion JPY | -3.94% |
| 2010 Q4 | 661.48 Billion JPY | 0.84% |
| 2010 Q2 | 682.87 Billion JPY | 3.41% |
| 2009 Q3 | 678.97 Billion JPY | 2.29% |
| 2009 FY | 660.22 Billion JPY | 0.53% |
| 2009 Q2 | 663.78 Billion JPY | 0.0% |
| 2009 Q4 | 660.22 Billion JPY | -2.76% |
| 2008 FY | 656.75 Billion JPY | 38.03% |
| 2007 FY | 475.81 Billion JPY | 3.89% |
| 2006 FY | 458.01 Billion JPY | 19.89% |
| 2005 FY | 382.04 Billion JPY | 58.29% |
| 2004 FY | 241.36 Billion JPY | 19.58% |
| 2003 FY | 201.84 Billion JPY | -5.59% |
| 2002 FY | 213.79 Billion JPY | -7.26% |
| 2001 FY | 230.51 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -72111700.0% |
| Ansell Limited | 855.59 Million USD | -42041.287% |
| Ansell Limited | 857.2 Million USD | -41962.413% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -1608707.918% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -1722278381.013% |
| Psykey, Inc. | 1.01 Million USD | -35677616.208% |
| ConvaTec Group Plc | 1.31 Billion USD | -27412.102% |
| ConvaTec Group Plc | 1.31 Billion USD | -27373.255% |
| Encision Inc. | 1.33 Million USD | -27044488.892% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -15617188.737% |
| Innovative MedTech Inc. | 1.87 Million USD | -19196694.846% |
| LifePoint, Inc. | 446.74 Thousand USD | -80708813.462% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -6684120.147% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -16471302.467% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -148595785.33% |
| SmileDirectClub, Inc. | 871.79 Million USD | -41258.137% |
| Sector 10, Inc. | 164 Thousand USD | -219852948.78% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | -53394.463% |
| SheerVision, Inc. | 75 Thousand USD | -480745233.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -47693583.374% |
| Vasamed, Inc. | 23.45 Thousand USD | -1537564931.983% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -13028840.836% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -45611469.401% |